Clinical Trials Logo

Filter by:
  • Completed  
  • Page [1] ·  Next »
NCT ID: NCT06413082 Completed - Hypertension Clinical Trials

Pharmacogenetics of Torasemide and Spironolactone in Hypertension Treatment

ALTUM
Start date: February 15, 2021
Phase: Phase 3
Study type: Interventional

Phase III interventional study to evaluate the different efficacy of Torasemide and Spironolactone in reducing systolic blood pressure in carriers and non-carriers of the different genotypic combinations for Lanosterol and Uromodulin

NCT ID: NCT06412705 Completed - Clinical trials for Vitamin D Deficiency

Vit D and Post-extractive Bone Turnover

Start date: October 2, 2023
Phase: N/A
Study type: Interventional

The aims of the study was to correlate the extent of the dimensional alveolar bone changes after tooth extraction and contextual guided bone regeneration with serum vit D levels in 14 patients. Moreover, at 4 months, a small bone sample was collected in order to correlate histological and immunohistochemical parameters of bone with vit D serum levels.

NCT ID: NCT06410560 Completed - Clinical trials for Well-Being, Psychological

Culture is Care: Training Workshop for Care Workers (VerbaCurant)

VerbaCurant
Start date: March 18, 2021
Phase: N/A
Study type: Interventional

The study aims to measure the empathic capacity of healthcare professionals belonging to the Alessandria Hospital, by applying validated measuring instruments, before and after a specific training intervention. The secondary objective is to assess how the training initiative impacts on subjects with a different attitude towards cultural participation.

NCT ID: NCT06409546 Completed - Clinical trials for Medically Related Osteonecrosis of the Jaws

Impact of Topical Pentoxifylline and Tocopherol in Treatment and Prevention of Medically-related Osteonecrosis of the Jaws

Start date: April 2, 2020
Phase: N/A
Study type: Interventional

While there is no doubt about the benefits of antiresorptives, it is known that patients using these drugs are at increased risk of developing osteonecrosis of the jaws (MRNOJ), especially after oral procedures such as tooth extraction. The management of osteonecrosis has remained a controversial topic within the oral and maxillofacial surgery community. The aim of the present study is to analyze the impact of topical pentoxifilline and tocopherol in the prevention and treatment of MRNOJ.

NCT ID: NCT06408805 Completed - Clinical trials for Hereditary Angioedema

Autonomic Nervous System Profile in Hereditary Angioedema

ANS-HAE
Start date: July 12, 2023
Phase:
Study type: Observational

The goal of this study is to compare the autonomic nervous system control of patients with hereditary angioedema to healthy individuals. The main questions it aims to answer are: Are there differences in the autonomic nervous system control between patients with hereditary angioedema and healthy individuals during short-term resting period and during orthostatic challenges? Are there differences in the autonomic nervous system control recorded over long-term periods (i.e. 24 hours)?

NCT ID: NCT06408324 Completed - Clinical trials for Primary Immune Thrombocytopenia (ITP)

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Start date: November 24, 2022
Phase:
Study type: Observational

The goal of this multicenter, observational, retrospective is to evaluate the standards of use of thrombopoietin receptor agonists (TPO-RA) in adult patients with primary immune thrombocytopenia (ITP), with a particular interest on phase of ITP (defined according to time when diagnosis of ITP is established in the medical records: newly diagnosed, 0-3 months; persistent, 3-12 months, and chronic, > 12 months), tolerability, safety, posology and remissions, outside controlled clinical trials. Secondary Objectives: To analyze the patient characteristics that could affect the choice of thrombopoietin receptor agonist for the treatment of ITP, considering specific clinical aspects (such as previous thromboembolic disease, bleeding, platelet count, surgical procedures, etc.). To evaluate the degree of adherence to international guidelines related to the use of thrombopoietin receptor agonists in regular clinical practice. Data will be collected through a retrospective chart review of patients with ITP who started TPO-RA treatment between January 2014 and December 2018.

NCT ID: NCT06407609 Completed - Clinical trials for Irritable Bowel Syndrome

Positive Outcomes of the Supplementation With Lecithin-based Delivery Form of Curcuma Longa and of Boswellia Serrata in IBS

Start date: September 3, 2022
Phase: N/A
Study type: Interventional

Small bowel dysbiosis (SBD), is a frequent finding in subjects with irritable bowel syndrome (IBS). The formula-tion in sunflower lecithin (Phytosome) of Curcuma longa and Boswellia serrata demonstrated beneficial effects on intestinal microbiota. The aim of this study was to evaluate the effect of a lecithin-based delivery formulation of Curcuma longa and of Boswellia serrata extracts (CUBO), on SBD in IBS subjects.

NCT ID: NCT06404853 Completed - Clinical trials for Constipation - Functional

Effect and Safety of the Dietary Supplement Mannite in Pediatric Patients With Chronic Functional Constipation

MANNAPED
Start date: March 16, 2021
Phase: N/A
Study type: Interventional

Functional constipation is a widely prevalent pediatric issue, with a prevalence in some studies as high as 32.2%. Treatment consists of a combination of behavioral and pharmacological interventions (mainly, administration of polyethylene glycol laxatives or the use of enemas). Glucomannan (GNN) is a polysaccharide of 1,4-D-glucose and D-mannose found in the soluble fiber of some plants. While studies available in the literature to date agree that mannite is a dietary supplement with safe use, the usefulness of this compound remains controversial.

NCT ID: NCT06403358 Completed - Diarrhea Clinical Trials

Study for Evaluation of Probiotics in the Re-equilibration of the Intestinal Microbiota, in Paediatric Age

Start date: November 28, 2022
Phase:
Study type: Observational

To evaluate the efficacy, safety and hydration index about the oral administration of probiotics food supplement in the re-equilibration of the intestinal microbiota, in presence of acute diarrhea

NCT ID: NCT06398522 Completed - Metabolic Syndrome Clinical Trials

Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

This was a double-blind, randomized, placebo-controlled clinical study aiming to assess the effect of a food for special medical purposes with functional release containing calcium butyrate, zinc gluconate and vitamin D3 on liver steatosis in individuals with NAFLD and metabolic syndrome